Chen YC, Yu BH, Chiou WY. Reply to Li, A.-H.; Chiu, Y.-L. Drug-Drug Interactions, Medication Adherence, and Stroke Should Be Considered When Approaching the Impact of Acid Suppression Therapy on Chronic Kidney Disease Patients. Comment on "Chen et al. Impact of Acid Suppression Therapy on Renal and Survival Outcomes in Patients with Chronic Kidney Disease: A Taiwanese Nationwide Cohort Study. J. Clin. Med. 2022, 11, 5612". J Clin Med 2022;12. [PMID: 36614972 DOI: 10.3390/jcm12010171][Reference Citation Analysis]
2
Li AH, Chiu YL. Drug-Drug Interactions, Medication Adherence, and Stroke Should Be Considered When Approaching the Impact of Acid Suppression Therapy on Chronic Kidney Disease Patients. Comment on Chen et al. Impact of Acid Suppression Therapy on Renal and Survival Outcomes in Patients with Chronic Kidney Disease: A Taiwanese Nationwide Cohort Study. J. Clin. Med. 2022, 11, 5612. J Clin Med 2022;12. [PMID: 36614873 DOI: 10.3390/jcm12010072][Cited by in Crossref: 1][Cited by in F6Publishing: 1][Article Influence: 1.0][Reference Citation Analysis]
3
Yu B, Chen Y, Li Y, Chiou W, Chen Y. No dose-response relationship of clarithromycin utilization on cardiovascular outcomes in patients with stable coronary heart disease: Analysis of Taiwan’s national health insurance claims data. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.1018194][Reference Citation Analysis]
